Business Daily from THE HINDU group of publications
Wednesday, Jan 10, 2007
ePaper
Business Daily from THE HINDU group of publications Wednesday, Jan 10, 2007 ePaper |
|
|
|
|
|
|
|
Corporate
-
IPR Suven Life gets EU patent for therapeutic agent Our Bureau
Hyderabad, Jan. 9 Suven Life Sciences Ltd (SLSL) has obtained a European patent on a novel Serotonin Receptor Ligands, which are being developed as therapeutic agents soon. The company announced today that the European Patent Office (EPO) issued the Patent 1517909 titled "Novel Tetracyclic Arylcarbonylindoles having Serotonin Receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them." The patent would be valid until June 2023. The granted claims of the patent include the class of selective 5-HT compounds that would be useful in the treatment of cognitive impairment associated with neuro-degenerative disorders such as attention deficient hyperactivity, Alzheimer's, Parkinson, Schizophrenia and Huntington's. "We continue to work on G-Protein coupled receptor targets to discover and develop molecules focusing on CNS disorders with unmet medical need and high market potential," said Mr Venkat Jasti, CEO of the company.
More Stories on : IPR | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2007, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|